WYNYARD, UK, Feb. 21,
2023 /PRNewswire/ --
Fourth Quarter 2022 and Other Highlights
- The macro-economic environment deteriorated sharply in the
second half of 2022 leading to significantly lower product demand
and higher raw material and energy costs, with TiO2
sales volumes (44)% lower compared to the fourth quarter 2021 and
(28)% lower compared to the prior period
- Net loss attributable to Venator of $(228) million compared to net income of
$14 million in the prior year
period
- Adjusted EBITDA of $(57) million
compared to $40 million in the prior
year period
- Net cash used in operating activities was $(27) million and free cash flow was $(48) million
- Diluted loss per share of $(2.11)
and adjusted diluted loss per share of $(0.20)
- Venator has initiated a $50
million cost reduction program
- Closed a sale-leaseback transaction for Color Pigments
manufacturing facility in Los Angeles,
California for $51 million on
October 7, 2022
- On November 14, 2022 entered into
a definitive agreement to divest the iron oxide business from
within the Color Pigments business to Cathay Industries for an
enterprise value of $140 million
- In-depth strategic operational and capital structure review
continues, bolstered by the appointment of two new independent
directors, Stefan M. Selig and
Jame Donath, who bring extensive and
highly relevant experience to the Board
Full-Year 2022 Highlights
- Net loss attributable to Venator of $(188) million compared to $(77) million in the prior year
- Adjusted EBITDA of $53 million
compared to $180 million in the prior
year
- Net cash used in operating activities of $(114) million and free cash flow of $(183) million
- Diluted loss per share of $(1.74)
and adjusted diluted loss per share of $(0.34)
|
|
Three months
ended
|
|
Twelve months
ended
|
|
|
December
31,
|
|
September 30,
2022
|
|
December
31,
|
(In millions, except per share amounts)
|
|
2022
|
|
2021
|
|
|
2022
|
|
2021
|
Revenues
|
|
$
366
|
|
$
535
|
|
$
506
|
|
$
2,173
|
|
$
2,212
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income
attributable to Venator
|
|
$
(228)
|
|
$ 14
|
|
$
(50)
|
|
$
(188)
|
|
$ (77)
|
Adjusted net
(loss) (2)
|
|
$ (22)
|
|
$ (5)
|
|
$
(36)
|
|
$ (37)
|
|
$
(1)
|
Adjusted
EBITDA(1)
|
|
$ (57)
|
|
$ 40
|
|
$
(8)
|
|
$ 53
|
|
$ 180
|
|
|
|
|
|
|
|
|
|
|
|
Diluted (loss) income
per share
|
|
$
(2.11)
|
|
$
0.13
|
|
$
(0.46)
|
|
$
(1.74)
|
|
$
(0.72)
|
Adjusted diluted (loss)
earnings per share(1). (4)
|
|
$
(0.20)
|
|
$ (0.05)
|
|
$
(0.33)
|
|
$
(0.34)
|
|
$
(0.01)
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in)
provided by operating activities
|
|
$ (27)
|
|
$ 17
|
|
$
(74)
|
|
$
(114)
|
|
$ 19
|
Free cash
flow(3)
|
|
$ (48)
|
|
$ (9)
|
|
$
(90)
|
|
$
(183)
|
|
$ (54)
|
Venator Materials PLC ("Venator") (NYSE: VNTR) today reported
fourth quarter 2022 results with revenues of $366 million, net loss attributable to Venator of
$(228) million, adjusted net loss of
$(22) million and adjusted EBITDA
of $(57) million.
Simon Turner, President and
CEO of Venator, commented:
"The year started well with strong TiO2 demand across
all regions which enabled us to increase prices and offset cost
inflation. However, the macroeconomic environment deteriorated
sharply in the second half of 2022 due to significantly lower
product demand and higher raw material and energy costs. This
presented a material challenge to our business and put pressure on
margins, though our Performance Additives segment has been more
resilient.
"We have seen some recovery in TiO2 sales volumes and
believe that destocking in Europe
has primarily run its course, though underlying demand remains
weak. We expect first quarter adjusted EBITDA to be meaningfully lower than the fourth quarter
as higher sales volumes are expected to be more than offset by
lower selling prices and higher cost of goods sold.
"We are taking steps to manage cash while continuing to improve
our overall operations and expect to complete the sale of our iron
oxide business to Cathay Industries by the end of the first
quarter. Our in-depth strategic review is progressing as we
continue to explore additional actions to bolster liquidity and
establish a sustainable capital structure. We welcome continued
dialogue with our shareholders, debtholders, and all other
stakeholders on supporting Venator through this process."
Segment Analysis for Fourth Quarter 2022 Compared to Fourth
Quarter 2021
Titanium Dioxide
The Titanium Dioxide segment
generated revenues of $240 million in
the three months ended December 31,
2022, a decrease of $166
million, or 41%, compared to the same period in 2021. The
decrease was primarily due to a 44% decrease in sales volumes and a
5% unfavorable impact of foreign currency translation as the Euro
strengthened against the U.S. Dollar, partially offset by an 8%
increase in the average TiO2 selling price. The decrease
in sales volumes is due to weak demand across all regions.
Adjusted EBITDA for the Titanium Dioxide segment was a loss of
$50 million in the three months ended
December 31, 2022, a decrease of
$85 million compared to the same
period in 2021. The decrease was primarily due to lower sales
volumes and an increase in raw material and energy costs.
Performance Additives
The Performance Additives
segment generated revenues of $126
million in the three months ended December 31, 2022, a decrease of $3 million, or 2%, compared to the same period in
2021. This decrease was a result of a 22% decrease in sales
volumes, a 5% unfavorable impact of foreign currency translation as
the Euro strengthened against the U.S. Dollar and a 2% unfavorable
impact from mix and other. This was partially offset by a 27%
increase in average selling price. The decrease in volume was
primarily driven by weak demand across all regions.
Adjusted EBITDA for the Performance Additives segment was
$5 million in the three months ended
December 31, 2022, a decrease of
$14 million compared to the same
period in 2021. The decrease in adjusted EBITDA was primarily
related to an increase in raw material and energy costs and lower
sales volumes.
Corporate and Other
Corporate and Other represents
expenses which are not allocated to our segments. Losses from
Corporate and Other were $12 million,
or $2 million lower for the three
months ended December 31, 2022,
compared to the same period in 2021 due to lower personnel
costs.
Tax Items
We recorded an income tax expense of
$(45) million and $(63) million for the three and twelve months
ended December 31, 2022,
respectively, compared to an income tax benefit of $45 million and $31
million for the three and twelve months ended December 31, 2021, respectively. $(50) million of tax expense was recognized in
the fourth quarter of 2022 in connection with recognizing a
valuation allowance against certain net deferred tax assets
compared with a $47 million of tax
benefit recognized in the fourth quarter of 2021 in connection with
recognizing certain net deferred tax assets as a result of
releasing a tax valuation allowance. Our adjusted effective tax
rate was unchanged at 35% for the full year 2022 and full year
2021.
Our income taxes are significantly affected by the mix of income
and losses in tax jurisdictions and valuation allowances in certain
jurisdictions in which we operate. In 2023, we expect to see an
adjusted effective tax rate of approximately 25%. We continue to
expect that our adjusted long-term effective tax rate will be
approximately 20% to 25%.
Liquidity and Capital Resources
As of December 31, 2022, we had cash and cash
equivalents of $114 million and
$162 million of availability under
our asset based revolving credit facility. As of February 17, 2023, our liquidity has reduced to
$134 million consisting of
$97 million of cash and cash
equivalents and approximately $37
million of available liquidity under our ABL facility as a
result of borrowings made during 2023 and discretionary reserves
imposed by the lenders. We expect our ability to utilize this
liquidity will be limited due to lender reserves and other
limitations.
We expect our 2022 financial statements to be issued with
explanatory language about our ability to continue as a going
concern. As a result, we have classified our debt as current on our
audited consolidated balance sheet for the year ended December 31, 2022. As of December 31, 2022, net debt was $933 million compared to $798 million as of December 31, 2021.
On November 14, 2022, we entered
into a definitive agreement to divest the iron oxide business from
within the Color Pigments business to Cathay Industries for an
enterprise value of $140 million.
Based on the carve out financial statements dated December 31, 2022 we estimate cash proceeds to be
approximately $135 million net of
working capital adjustments, taxes, fees and other closing cash
adjustments. As a result of this transaction, we estimate that the
borrowing base on our ABL will reduce by approximately $55 million resulting in an estimated net
liquidity improvement of approximately $80
million.
Capital expenditures totaled $21
million in the fourth quarter of 2022 and $69 million in the full year 2022. We expect
capital expenditures in 2023 to total approximately $55 to $60 million, which consists primarily
of maintenance capital expenditure and excludes capital
expenditures for our iron oxide business.
Strategic Operational and Capital Structure Review
We
are undertaking an in-depth strategic review of our business to
improve our operations, strengthen our liquidity position, and
establish a sustainable capital structure. We have appointed Moelis
& Company and Kirkland & Ellis as respective financial and
legal advisors, in addition to Alvarez & Marsal as the
previously engaged operational advisor, to assist with strategic
review and engagement with stakeholders.
We continue to operate our Scarlino TiO2 facility at
one third of its 80,000 ton nameplate capacity to reduce the rate
at which the remaining gypsum capacity is consumed. At the current
operating rate, we will soon have insufficient capacity for the
gypsum produced and as a consequence expect to stop production
during the second quarter of 2023. If we do not receive approvals
for additional gypsum storage capacity by the end of the first
quarter of 2023, we may permanently close the site and subsequently
incur associated site closure costs.
Following the COVID-19 pandemic and ongoing weak demand in
Asia there has been lower demand
for our fibers and active materials TiO2 products which
are manufactured at our 50,000 ton Duisburg TiO2
facility. This manufacturing site has been significantly impacted
by higher inflationary costs resulting in unsustainably low
TiO2 contribution margins. We have taken steps to reduce
the economic impact on our business by shutting down the site
during the fourth quarter of 2022 and first quarter of 2023 and by
furloughing most of our employees at the site. We are in the
process of restarting production for both TiO2 and
functional additives in the first quarter of 2023, however we do
not believe it is economically viable to continue TiO2
production longer term. We therefore intend to permanently close
TiO2 production at our Duisburg site unless economic
conditions meaningfully improve. As a result, we will engage with
the relevant works council when required. We intend to transfer the
production of certain specialty TiO2 products to other
sites with lower manufacturing costs.
Along with our advisors, we have commenced discussions with key
stakeholders, as we evaluate all options to establish a sustainable
capital structure. We welcome continued dialogue with our
shareholders and debtholders on supporting Venator through this
process. In the event that the strategic review concludes there is
a need for deleveraging and/or equitization of part of Venator's
debt, this will very likely result in material dilution of the
existing share capital.
Earnings Conference Call Information
We plan to hold a
conference call to discuss our fourth quarter and full-year 2022
results on, Tuesday February 21, 2023, at 08:00
a.m. ET.
Call-in numbers for the
conference call:
|
U.S.
participants
|
1-833-366-1118
|
International
participants
|
1-412-902-6770
|
(No passcode
required)
|
|
You may use the following link to pre-register for the
conference call. Callers who pre-register will be given a unique
PIN and separate call-in number to gain immediate access to the
call and bypass the live operator. To pre-register, please go
to:
https://dpregister.com/sreg/10174867/f5994840d5
Webcast Information
The conference call will be
available via webcast and can be accessed from the company's
website at venatorcorp.com/investor-relations.
Replay Information
The conference call will be
available for replay beginning February 21, 2023 and ending
February 28, 2023.
Call-in numbers for the
replay:
|
U.S.
participants
|
1-877-344-7529
|
International
participants
|
1-412-317-0088
|
Passcode
|
1948485
|
Table 1 — Results of
Operations
|
|
|
|
Three months
ended
|
|
Twelve months
ended
|
|
|
December
31,
|
|
December
31,
|
(In millions, except per share amounts)
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
Revenues
|
|
$
366
|
|
$
535
|
|
$
2,173
|
|
$
2,212
|
Cost of goods
sold
|
|
411
|
|
491
|
|
2,088
|
|
2,020
|
Operating (income)
expenses
|
|
(3)
|
|
53
|
|
92
|
|
182
|
Restructuring,
impairment, and plant closing and transition costs
|
|
121
|
|
8
|
|
142
|
|
68
|
Operating
loss
|
|
(163)
|
|
(17)
|
|
(149)
|
|
(58)
|
Interest expense,
net
|
|
(17)
|
|
(15)
|
|
(61)
|
|
(59)
|
Other income
|
|
(1)
|
|
2
|
|
92
|
|
12
|
Loss before income
taxes
|
|
(181)
|
|
(30)
|
|
(118)
|
|
(105)
|
Income tax benefit
(expense)
|
|
(45)
|
|
45
|
|
(63)
|
|
31
|
Net income
(loss)
|
|
(226)
|
|
15
|
|
(181)
|
|
(74)
|
Net income attributable
to noncontrolling interests
|
|
(2)
|
|
(1)
|
|
(7)
|
|
(3)
|
Net income (loss)
attributable to Venator
|
|
$ (228)
|
|
$
14
|
|
$ (188)
|
|
$
(77)
|
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA(1)
|
|
$ (57)
|
|
$
40
|
|
$
53
|
|
$ 180
|
Adjusted net
loss(1)
|
|
$ (22)
|
|
$
(5)
|
|
$ (37)
|
|
$
(1)
|
|
|
|
|
|
|
|
|
|
Basic & diluted
earnings (loss) per share
|
|
$
(2.11)
|
|
$ 0.13
|
|
$
(1.74)
|
|
$
(0.72)
|
Adjusted basic &
diluted loss per share(1,4)
|
|
$
(0.20)
|
|
$
(0.05)
|
|
$
(0.34)
|
|
$
(0.01)
|
|
|
|
|
|
|
|
|
|
Ordinary share
information:
|
|
|
|
|
|
|
|
|
Basic shares
outstanding
|
|
108.0
|
|
107.3
|
|
107.9
|
|
107.2
|
Diluted shares
outstanding
|
|
108.0
|
|
107.7
|
|
107.9
|
|
107.2
|
|
See end of press
release for footnote explanations
|
Table 2 — Results of
Operations by Segment
|
|
|
|
Three months
ended
|
|
|
|
Twelve months
ended
|
|
|
|
|
December
31,
|
|
Better
/
|
|
December
31,
|
|
Better
/
|
(In millions)
|
|
2022
|
|
2021
|
|
(Worse)
|
|
2022
|
|
2021
|
|
(Worse)
|
Segment
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Titanium
Dioxide
|
|
$ 240
|
|
$ 406
|
|
(41) %
|
|
$
1,597
|
|
$
1,665
|
|
(4) %
|
Performance
Additives
|
|
126
|
|
129
|
|
(2) %
|
|
576
|
|
547
|
|
5 %
|
Total
|
|
$ 366
|
|
$ 535
|
|
(32) %
|
|
$
2,173
|
|
$
2,212
|
|
(2) %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Adjusted
EBITDA(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
Titanium
Dioxide
|
|
$ (50)
|
|
$
35
|
|
(243) %
|
|
$
43
|
|
$ 165
|
|
(74) %
|
Performance
Additives
|
|
5
|
|
19
|
|
(74) %
|
|
53
|
|
65
|
|
(18) %
|
Corporate and
other
|
|
(12)
|
|
(14)
|
|
14 %
|
|
(43)
|
|
(50)
|
|
14 %
|
Total
|
|
$
(57)
|
|
$
40
|
|
(243) %
|
|
$
53
|
|
$ 180
|
|
(71) %
|
|
See end of press
release for footnote explanations
|
Table 3 — Factors
Impacting Sales Revenue
|
|
|
Three months
ended
|
|
December 31, 2022
vs. 2021
|
|
Average Selling Price(a)
|
|
|
|
|
|
|
|
Local
Currency
|
|
Exchange
Rate
|
|
Sales Mix
& Other
|
|
Sales
Volume(b)
|
|
Total
|
Titanium
Dioxide
|
8 %
|
|
(5) %
|
|
— %
|
|
(44) %
|
|
(41) %
|
Performance
Additives
|
27 %
|
|
(5) %
|
|
(2) %
|
|
(22) %
|
|
(2) %
|
Total
Company
|
12 %
|
|
(5) %
|
|
(1) %
|
|
(38) %
|
|
(32) %
|
|
Twelve months
ended
|
|
December 31, 2022
vs. 2021
|
|
Average Selling Price(a)
|
|
|
|
|
|
|
|
|
|
Local
Currency
|
|
Exchange
Rate
|
|
Sales Mix
& Other
|
|
Sales
Volume(b)
|
|
Divestitures
(c)
|
|
Total
|
Titanium
Dioxide
|
22 %
|
|
(7) %
|
|
— %
|
|
(19) %
|
|
— %
|
|
(4) %
|
Performance
Additives
|
26 %
|
|
(5) %
|
|
(1) %
|
|
(13) %
|
|
(2) %
|
|
5 %
|
Total
Company
|
23 %
|
|
(6) %
|
|
— %
|
|
(18) %
|
|
(1) %
|
|
(2) %
|
|
(a)
Excludes revenues from tolling arrangements, by-products and raw
materials
|
(b)
Excludes sales volumes of by-products and raw materials
|
(c)
Our water treatment business was disposed of in the second quarter
of 2021
|
Table 4 —
Reconciliation of U.S. GAAP to Non-GAAP Measures
|
|
|
|
EBITDA
|
|
Net Income
(Loss)
|
|
Diluted Earnings
(Loss) Per Share
|
|
|
Three months
ended
|
|
Three months
ended
|
|
Three months
ended
|
|
|
December
31,
|
|
December
31,
|
|
December
31,
|
(In millions, except per share amounts)
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
Net income
(loss)
|
|
$
(226)
|
|
$
15
|
|
$
(226)
|
|
$ 15
|
|
$
(2.09)
|
|
$
0.14
|
Net income attributable
to noncontrolling interests
|
|
(2)
|
|
(1)
|
|
(2)
|
|
(1)
|
|
(0.02)
|
|
(0.01)
|
Net income (loss)
attributable to Venator
|
|
(228)
|
|
14
|
|
(228)
|
|
14
|
|
(2.11)
|
|
0.13
|
Interest expense,
net
|
|
17
|
|
15
|
|
|
|
|
|
|
|
|
Income tax (benefit)
expense
|
|
45
|
|
(45)
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
23
|
|
30
|
|
|
|
|
|
|
|
|
Business acquisition
and integration credits
|
|
1
|
|
1
|
|
1
|
|
1
|
|
0.01
|
|
0.01
|
Separation
gain
|
|
2
|
|
3
|
|
2
|
|
3
|
|
0.02
|
|
0.03
|
Loss/(gain) on
disposition of businesses/assets
|
|
(39)
|
|
7
|
|
(39)
|
|
7
|
|
(0.36)
|
|
0.07
|
Certain legal
expenses/settlements
|
|
2
|
|
1
|
|
2
|
|
1
|
|
0.02
|
|
0.01
|
Amortization of pension
and postretirement actuarial losses
|
|
—
|
|
2
|
|
—
|
|
2
|
|
—
|
|
0.02
|
Net plant incident
costs
|
|
(1)
|
|
4
|
|
(1)
|
|
4
|
|
(0.01)
|
|
0.04
|
Restructuring,
impairment, plant closing and transition costs
|
|
121
|
|
8
|
|
121
|
|
8
|
|
1.12
|
|
0.07
|
Income tax
adjustments(2)
|
|
—
|
|
—
|
|
120
|
|
(45)
|
|
1.11
|
|
(0.42)
|
Adjusted(1)
|
|
$
(57)
|
|
$
40
|
|
$
(22)
|
|
$
(5)
|
|
$
(0.20)
|
|
$
(0.05)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted income tax
expense(2)
|
|
|
|
|
|
$
(75)
|
|
$ —
|
|
|
|
|
Net income attributable
to noncontrolling interests, net of tax
|
|
|
|
|
|
2
|
|
1
|
|
|
|
|
Adjusted pre-tax
loss(1)
|
|
|
|
|
|
$
(95)
|
|
$
(4)
|
|
|
|
|
Adjusted effective
tax rate
|
|
|
|
|
|
35 %
|
|
35 %
|
|
|
|
|
|
|
EBITDA
|
|
Net Income
(Loss)
|
|
Diluted Earnings
(Loss) Per Share
|
|
|
Three months
ended
|
|
Three months
ended
|
|
Three months
ended
|
|
|
September
30,
|
|
September
30,
|
|
September
30,
|
(In millions, except per share amounts)
|
|
2022
|
|
2022
|
|
2022
|
Net
loss
|
|
$
(48)
|
|
$
(48)
|
|
$
(0.44)
|
Net income attributable
to noncontrolling interests
|
|
(2)
|
|
(2)
|
|
(0.02)
|
Net loss
attributable to Venator
|
|
(50)
|
|
(50)
|
|
(0.46)
|
Interest expense,
net
|
|
16
|
|
|
|
|
Income tax
expense
|
|
4
|
|
|
|
|
Depreciation and
amortization
|
|
27
|
|
|
|
|
Certain legal
expenses/settlements
|
|
—
|
|
—
|
|
—
|
Amortization of pension
and postretirement actuarial losses
|
|
1
|
|
1
|
|
0.01
|
Net plant incident
costs
|
|
(11)
|
|
(11)
|
|
(0.10)
|
Restructuring,
impairment, plant closing and transition costs
|
|
5
|
|
5
|
|
0.05
|
Income tax
adjustments(2)
|
|
—
|
|
19
|
|
0.18
|
Adjusted(1)
|
|
$
(8)
|
|
$
(36)
|
|
$
(0.33)
|
|
|
|
|
|
|
|
Adjusted income tax
expense(2)
|
|
|
|
$
(15)
|
|
|
Net income attributable
to noncontrolling interests, net of tax
|
|
|
|
2
|
|
|
Adjusted pre-tax
income(1)
|
|
|
|
$
(49)
|
|
|
Adjusted effective
tax rate
|
|
|
|
35 %
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
|
|
Net Income
(Loss)
|
|
Diluted Earnings
(Loss) Per Share
|
|
|
Twelve months
ended
|
|
Twelve months
ended
|
|
Twelve months
ended
|
|
|
December
31,
|
|
December
31,
|
|
December
31,
|
(In millions, except per share amounts)
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
Net
loss
|
|
$
(181)
|
|
$
(74)
|
|
$
(181)
|
|
$
(74)
|
|
$
(1.68)
|
|
$
(0.69)
|
Net income attributable
to noncontrolling interests
|
|
(7)
|
|
(3)
|
|
(7)
|
|
(3)
|
|
(0.06)
|
|
(0.03)
|
Net loss
attributable to Venator
|
|
(188)
|
|
(77)
|
|
(188)
|
|
(77)
|
|
(1.74)
|
|
(0.72)
|
Interest expense,
net
|
|
61
|
|
59
|
|
|
|
|
|
|
|
|
Income tax (benefit)
expense
|
|
63
|
|
(31)
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
107
|
|
119
|
|
|
|
|
|
|
|
|
Business acquisition
and integration expenses
|
|
1
|
|
1
|
|
1
|
|
1
|
|
0.01
|
|
0.01
|
Separation loss
(gain)
|
|
2
|
|
3
|
|
2
|
|
3
|
|
0.02
|
|
0.03
|
Loss (gain) on
disposition of businesses/assets
|
|
(40)
|
|
9
|
|
(40)
|
|
9
|
|
(0.37)
|
|
0.08
|
Certain legal
expenses/settlements
|
|
(81)
|
|
5
|
|
(81)
|
|
5
|
|
(0.75)
|
|
0.05
|
Amortization of pension
and postretirement actuarial losses
|
|
2
|
|
11
|
|
2
|
|
11
|
|
0.02
|
|
0.10
|
Net plant incident
costs
|
|
(16)
|
|
13
|
|
(16)
|
|
13
|
|
(0.15)
|
|
0.12
|
Restructuring,
impairment, plant closing and transition costs
|
|
142
|
|
68
|
|
142
|
|
68
|
|
1.32
|
|
0.63
|
Income tax
adjustments(2)
|
|
—
|
|
—
|
|
141
|
|
(34)
|
|
1.31
|
|
(0.32)
|
Adjusted(1)
|
|
$
53
|
|
$
180
|
|
$
(37)
|
|
$
(1)
|
|
$
(0.34)
|
|
$
(0.01)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted income tax
benefit (expense)(2)
|
|
|
|
|
|
$
(78)
|
|
$
3
|
|
|
|
|
Net income attributable
to noncontrolling interests, net of tax
|
|
|
|
|
|
7
|
|
3
|
|
|
|
|
Adjusted pre-tax
income (loss)(1)
|
|
|
|
|
|
$
(108)
|
|
$
5
|
|
|
|
|
Adjusted effective
tax rate
|
|
|
|
|
|
35 %
|
|
35 %
|
|
|
|
|
|
See end of press
release for footnote explanations
|
Table 5 — Selected
Balance Sheet Items
|
|
|
|
December
31,
|
|
September
30,
|
|
December
31,
|
(In millions)
|
|
2022
|
|
2022
|
|
2021
|
Cash
|
|
$
114
|
|
$
45
|
|
$
156
|
Accounts and notes
receivable, net
|
|
247
|
|
340
|
|
371
|
Inventories
|
|
499
|
|
596
|
|
478
|
Prepaid and other
current assets
|
|
75
|
|
101
|
|
84
|
Assets held for
sale
|
|
198
|
|
—
|
|
—
|
Property, plant and
equipment, net
|
|
640
|
|
693
|
|
848
|
Other assets
|
|
296
|
|
369
|
|
427
|
Total
assets
|
|
$
2,069
|
|
$
2,144
|
|
$
2,364
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$
285
|
|
$
352
|
|
$
377
|
Other current
liabilities
|
|
109
|
|
113
|
|
131
|
Liabilities held for
sale
|
|
94
|
|
—
|
|
—
|
Current portion of
debt
|
|
1,041
|
|
24
|
|
5
|
Long-term
debt
|
|
6
|
|
947
|
|
949
|
Non-current payable to
affiliates
|
|
7
|
|
21
|
|
21
|
Other
liabilities
|
|
217
|
|
262
|
|
313
|
Total equity
|
|
310
|
|
425
|
|
568
|
Total liabilities
and equity
|
|
$
2,069
|
|
$
2,144
|
|
$
2,364
|
Table 6 —
Outstanding Debt
|
|
|
|
December
31,
|
|
September
30,
|
|
December
31,
|
(In millions)
|
|
2022
|
|
2022
|
|
2021
|
Debt:
|
|
|
|
|
|
|
Term Loan
Facility
|
|
$
353
|
|
$
354
|
|
$
356
|
Senior Secured
Notes
|
|
219
|
|
219
|
|
217
|
Senior Unsecured
Notes
|
|
373
|
|
373
|
|
372
|
ABL
Facility
|
|
80
|
|
—
|
|
—
|
Other debt
|
|
22
|
|
25
|
|
9
|
Total debt -
excluding affiliates
|
|
$
1,047
|
|
$
971
|
|
$
954
|
Total cash
|
|
114
|
|
45
|
|
156
|
Net debt - excluding
affiliates (5)
|
|
$
933
|
|
$
926
|
|
$
798
|
Table 7 — Summarized
Statement of Cash Flows
|
|
|
|
Three months
ended
|
|
Twelve months
ended
|
|
|
December
31,
|
|
December
31,
|
(In millions)
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
Total cash at
beginning of period
|
|
$
45
|
|
$
161
|
|
$
156
|
|
$
220
|
Net cash (used in)
provided by operating activities
|
|
(27)
|
|
17
|
|
(114)
|
|
19
|
Net cash provided by
(used in) investing activities
|
|
31
|
|
(13)
|
|
(24)
|
|
(60)
|
Net cash provided by
(used in) financing activities
|
|
62
|
|
(9)
|
|
99
|
|
(21)
|
Effect of exchange
rate changes on cash
|
|
3
|
|
—
|
|
(3)
|
|
(2)
|
Total cash at end of
period
|
|
$
114
|
|
$
156
|
|
$
114
|
|
$
156
|
|
|
|
|
|
|
|
|
|
Supplemental cash
flow information:
|
|
|
|
|
|
|
|
|
Cash paid for
interest
|
|
$
(7)
|
|
$
(4)
|
|
$
(64)
|
|
$
(62)
|
Cash paid for income
taxes
|
|
1
|
|
(9)
|
|
(4)
|
|
(14)
|
Capital
expenditures
|
|
(21)
|
|
(26)
|
|
(69)
|
|
(73)
|
Depreciation and
amortization
|
|
23
|
|
30
|
|
107
|
|
119
|
Restructuring
|
|
(4)
|
|
(4)
|
|
(20)
|
|
(11)
|
Net cash flows
associated with Pori
|
|
2
|
|
(2)
|
|
(7)
|
|
(12)
|
|
|
|
|
|
|
|
|
|
Changes in primary
working capital:
|
|
|
|
|
|
|
|
|
Accounts and notes
receivable
|
|
80
|
|
14
|
|
69
|
|
(65)
|
Inventories
|
|
26
|
|
(68)
|
|
(172)
|
|
(60)
|
Accounts
payable
|
|
(70)
|
|
56
|
|
(32)
|
|
120
|
Total cash provided
by (used in) primary working capital
|
|
$
36
|
|
$
2
|
|
$
(135)
|
|
$
(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Twelve months
ended
|
|
|
December
31,
|
|
December
31,
|
(In
millions)
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
Free cash
flow(3):
|
|
|
|
|
|
|
|
|
Net cash provided by
operating activities
|
|
$
(27)
|
|
$
17
|
|
$ (114)
|
|
$
19
|
Capital
expenditures
|
|
(21)
|
|
(26)
|
|
(69)
|
|
(73)
|
Total free cash
flow(3)
|
|
$
(48)
|
|
$
(9)
|
|
$
(183)
|
|
$
(54)
|
|
See end of press
release for numbered footnote explanations
|
Footnotes
|
|
|
(1)
|
Our management uses
adjusted EBITDA to assess financial performance. Adjusted EBITDA is
defined as net income/loss before interest income/expense, net,
income tax expense/benefit, depreciation and amortization, and net
income attributable to noncontrolling interests, as well as
eliminating the following adjustments: (a) business acquisition and
integration expense/credits; (b) separation gain/expense; (c)
loss/gain on disposition of businesses/assets; (d) certain legal
expenses/settlements; (e) amortization of pension and
postretirement actuarial losses/gains; (f) net plant incident
costs/credits; and (g) restructuring, impairment, and plant closing
and transition costs/credits. We believe that net income is the
performance measure calculated and presented in accordance with
U.S. GAAP that is most directly comparable to adjusted
EBITDA.
|
|
|
|
We believe adjusted
EBITDA is useful to investors in assessing our ongoing financial
performance and provides improved comparability between periods
through the exclusion of certain items that management believes are
not indicative of our operational profitability and that may
obscure underlying business results and trends. However, this
measure should not be considered in isolation or viewed as a
substitute for net income or other measures of performance
determined in accordance with U.S. GAAP. Moreover, adjusted EBITDA
as used herein is not necessarily comparable to other similarly
titled measures of other companies due to potential inconsistencies
in the methods of calculation. Our management believes this measure
is useful to compare general operating performance from period to
period and to make certain related management decisions. Adjusted
EBITDA is also used by securities analysts, lenders and others in
their evaluation of different companies because it excludes certain
items that can vary widely across different industries or among
companies within the same industry. For example, interest expense
can be highly dependent on a company's capital structure, debt
levels and credit ratings. Therefore, the impact of interest
expense on earnings can vary significantly among companies. In
addition, the tax positions of companies can vary because of their
differing abilities to take advantage of tax benefits and because
of the tax policies of the various jurisdictions in which they
operate. As a result, effective tax rates and tax expense can vary
considerably among companies. Finally, companies employ productive
assets of different ages and utilize different methods of acquiring
and depreciating such assets. This can result in considerable
variability in the relative costs of productive assets and the
depreciation and amortization expense among companies.
|
|
|
|
Nevertheless, our
management recognizes that there are limitations associated with
the use of adjusted EBITDA in the evaluation of us as compared to
net income. Our management compensates for the limitations of using
adjusted EBITDA by using this measure to supplement U.S. GAAP
results to provide a more complete understanding of the factors and
trends affecting the business rather than U.S. GAAP results
alone.
|
|
|
|
In addition to the
limitations noted above, adjusted EBITDA excludes items that may be
recurring in nature and should not be disregarded in the evaluation
of performance. However, we believe it is useful to exclude such
items to provide a supplemental analysis of current results and
trends compared to other periods because certain excluded items can
vary significantly depending on specific underlying transactions or
events, and the variability of such items may not relate
specifically to ongoing operating results or trends and certain
excluded items, while potentially recurring in future periods, may
not be indicative of future results.
|
|
|
|
Adjusted net income
(loss) attributable to Venator Materials PLC ordinary shareholders
is computed by eliminating the after-tax amounts related to the
following from net income/loss attributable to Venator Materials
PLC ordinary shareholders: (a) business acquisition and integration
expenses/adjustments; (b) loss/gain on disposition of
businesses/assets; (c) certain legal expenses/settlements; (d)
amortization of pension and postretirement actuarial losses/gains;
(e) net plant incident costs/credits; and (f) restructuring,
impairment, and plant closing and transition costs/credits. Basic
adjusted net income per share excludes dilution and is computed by
dividing adjusted net income by the weighted average number of
shares outstanding during the period. Adjusted diluted net income
per share reflects all potential dilutive ordinary shares
outstanding during the period increased by the number of additional
shares that would have been outstanding as dilutive
securities.
|
|
|
|
Adjusted net income
(loss) and adjusted net earnings (loss) per share amounts are
presented solely as supplemental information. These measures
exclude similar noncash items as Adjusted EBITDA in order to assist
our investors in comparing our performance from period to period
and as such, bear similar risks as Adjusted EBITDA as documented
above. For that reason, adjusted net income and the related per
share amounts, should not be considered in isolation and should be
considered only to supplement analysis of U.S. GAAP
results.
|
|
|
(2)
|
Income tax expense is
adjusted by the amount of additional tax expense or benefit that we
would accrue if we used non-GAAP results instead of GAAP results in
the calculation of our tax liability, taking into consideration our
tax structure. We used a normalized effective tax rate of 35% in
2022, and we estimate an effective tax rate of 25% in 2023, which
reflects the weighted average tax rate applicable under the various
jurisdictions in which we operate. This non-GAAP tax rate
eliminates the effects of non-recurring and period specific items
which are often attributable to restructuring and acquisition
decisions and can vary in size and frequency. This rate is subject
to change over time for various reasons, including changes in the
geographic business mix, valuation allowances, and changes in
statutory tax rates.
|
|
|
|
We eliminate the effect
of significant changes to income tax valuation allowances from our
presentation of adjusted net income to allow investors to better
compare our ongoing financial performance from period to period. We
do not adjust for insignificant changes in tax valuation allowances
because we do not believe it provides more meaningful information
than is provided under GAAP. We believe that our revised approach
enables a clearer understanding of the long-term impact of our tax
structure on post tax earnings.
|
|
|
(3)
|
Management internally
uses a free cash flow measure: (a) to evaluate the Company's
liquidity, (b) to evaluate strategic investments, (c) to evaluate
the Company's ability to incur and service debt. Free cash flow is
not a defined term under U.S. GAAP, and it should not be inferred
that the entire free cash flow amount is available for
discretionary expenditures. Free cash flow is defined as cash flows
provided by (used in) operating activities from continuing
operations less capital expenditures. The company updated its
definition of free cash flow during the third quarter of 2021 to
conform to the definition more commonly used by publicly traded
companies. Prior to the third quarter of 2021, free cash flow was
defined as cash flows provided by (used in) operating activities
from continuing operations and used in investing activities. Prior
period comparatives within this release have been restated for the
updated definition. Free cash flow is typically derived directly
from the Company's consolidated statement of cash flows; however,
it may be adjusted for items that affect comparability between
periods. Free cash flow is presented as supplemental
information.
|
|
|
(4)
|
The potentially
dilutive impact of share-based awards was excluded from the
calculation of earnings per share for the twelve months ended
December 31, 2022 and December 31, 2021 because there is an
anti-dilutive effect as we are in a net loss position.
|
|
|
(5)
|
"Net debt" is not a
defined term under U.S. GAAP. We define net debt as debt (the most
comparable GAAP measure, calculated as long-term obligations plus
short-term borrowings) minus cash and cash equivalents. Management
believes that net debt is an important measure to monitor leverage
and evaluate the balance sheet.
|
About Venator
Venator is a global manufacturer and
marketer of chemical products that comprise a broad range of
pigments and additives that bring color and vibrancy to buildings,
protect and extend product life, and reduce energy consumption. We
market our products globally to a diversified group of industrial
customers through two segments: Titanium Dioxide, which consists of
our TiO2 business, and Performance Additives, which
consists of our functional additives, color pigments and timber
treatment businesses. Based in Wynyard, U.K., Venator employs approximately
3,400 associates and sells its products in more than 109
countries.
Social Media:
Twitter:
www.twitter.com/VenatorCorp
Facebook: www.facebook.com/venatorcorp
LinkedIn: www.linkedin.com/company/venator-corp
Cautionary Statement Concerning Forward-Looking
Statements
Certain statements contained in this press
release constitute "forward-looking statements" within the meaning
of the U.S. Private Securities Litigation Reform Act of 1995. These
forward- looking statements represent Venator's expectations or
beliefs concerning future events, and it is possible that the
expected results described in this press release will not be
achieved. These forward looking statements are subject to risks,
uncertainties and other factors, many of which are outside of
Venator's control, that could cause actual results to differ
materially from the results discussed in the forward looking
statements, including volatile global economic conditions and a
downturn in the worldwide economy due to inflation, geopolitics,
changes in raw material and energy prices; interruptions in raw
materials and energy supply; economic and other impacts from the
military conflict in Ukraine and
the economic sanctions imposed due to the conflict; the impacts and
duration of the COVID-19 pandemic and the measures put in place by
governments in response; our ability to maintain sufficient working
capital; our ability to engage with shareholders and debtholders
with respect to our capital structure or access capital markets on
favorable terms or at all; our ability to explore and execute on
strategic alternatives, including by raising additional equity
capital or debt, by reducing or delaying our business activities,
by initiating reductions in force, by selling assets, by
restructuring, refinancing, purchasing, repaying or otherwise
retiring our outstanding debt; our ability to remain compliant with
all covenants in our debt agreements; the volatility in the price
of our ordinary shares, including as a result of us exploring
strategic alternatives; the costs associated with site closures,
including our Pori facility; the execution of our cost reduction
programs and initiatives; our ability to close the divestment of
the iron oxide business from within the Color Pigments business;
our ability to realize financial and operational benefits from our
cost reduction program and operational improvement plans and
initiatives; industry production capacity and operating rates; the
supply demand balance for our products and that of competing
products; pricing pressures; technological developments; legal
claims by or against us; changes in government regulations,
including increased manufacturing, labeling and waste disposal
regulations and the classification of TiO2 as a carcinogen in the
EU; management of materials resulting from our manufacturing
process, including the ability to develop commercial markets in the
regions in which we manufacture and our ability to dispose of these
materials if necessary; the impacts of increasing climate change
regulations; geopolitical events; cyberattacks; and public health
crises.
Any forward-looking statement speaks only as of the date on
which it is made, and, except as required by law, Venator does not
undertake any obligation to update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise. New factors emerge from time to time, and it is not
possible for Venator to predict all such factors. When considering
these forward-looking statements, you should keep in mind the risk
factors and other cautionary statements in Venator's Annual Report
on Form 20-F for the year ended December 31,
2022, filed with the SEC. The risk factors and other factors
noted therein could cause its actual results to differ materially
from those contained in any forward-looking statement.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/venator-announces-fourth-quarter-and-full-year-2022-results-strategic-review-underway-against-challenging-macroeconomic-backdrop-301751536.html
SOURCE Venator Materials PLC